|
Characteristics of tuberculosis patients in Yazd province, Islamic Republic of Iran, 1997–99 M.H. Salari1 and A.B. Kalantari2
1Department of Pathobiology, School
of Public Health;
2Institute of Public Health
Research, Tehran University of Medical Sciences, Tehran, Islamic Republic of
Iran.
|
| |
| Volume 10, Nos 1/2, January / March 2004, Pages 175 - 179 |
خصائص مرضى السل في مقاطعة يزد في إيران 1997 - 1999محمد حسين سلاري، أرد شير بهماردي كالانتاري الخلاصـة: حددت الدراسة معدل وقوع السل وبعض الخصائص الديمغرافية لدى 604 من المرضى خلال 3 سنوات (1997-1999) في مقاطعة يزد في إيران. وقد اتضح أن المعدل السنوي الوسطي لوقوع السل 26.8 لكل مئة ألـف (22.9 لدى الذكور و31.0 لدى الإناث لكل مئة ألف)، وقد كان أعلى معدل للسل بين من يزيد عمرهم علـى 50 عاماً (111.1 لكل مئة ألف). وكان العدد السنوي الوسطي لحالات السل الرئوي 76.1%) وخارج الرئوي 24.2%، وقد شفي من مرضى السل 66.7%، فيما نقل 8.4% إلى مناطق احتواء مختلفة، وعانى 17.7% منهم من فشل المعالجة، ومات 7.1% منهم. ومن بين المصابين كان 63.2% منهم إيرانيين و36.1% من اللاجئين الأفغان. ورغم جهود الوقاية والتشخيص والمعالجة للمرضى وللاجئين فإن السل لايزال يمثِّل مشكلة هامة في هذه المقاطعة. |
|
ABSTRACT We determined the incidence of tuberculosis and some demographic characteristics among 604 patients in a 3-year period (1997–99) in Yazd province, Islamic Republic of Iran. The average annual rate of tuberculosis was 26.8 per 100 000 (22.9 in males and 31.0 per 100 000 in females). The highest rate of tuberculosis was in the > 50 years age group (111.1 per 100 000). The average annual proportion of pulmonary and extra-pulmonary tuberculosis cases was 75.8% and 24.2% respectively. On average 66.7% of TB patients were cured, 8.4% transferred to a different catchment area, 17.7% were treatment failures and 7.1% died. Of the total, 63.2% were Iranian, 36.1% Afghan refugees. Despite efforts in prevention, diagnosis and treatment of patients and refugees, tuberculosis is still an important problem in this province. Caractéristiques des patients tuberculeux dans la province de Yazd (République islamique d’ Iran), 1997-1999 RESUME Cette étude a permis de déterminer l’incidence de la tuberculose ainsi que certaines caractéristiques démographiques chez 604 patients sur une période de trois ans (1997-1999) dans la province de Yazd (République islamique d’Iran). L’incidence annuelle moyenne de la tuberculose était de 26,8 pour 100 000 (22,9 chez les hommes et 31,0 chez les femmes). L’incidence la plus élevée se trouvait dans le groupe d’âge des plus de 50 ans (111,1 pour 100 000). La proportion annuelle moyenne de cas de tuberculose pulmonaire et extrapulmonaire était de 75,8 % et 24,2 % respectivement. En moyenne, 66,7 % des patients tuberculeux ont guéri, 8,4 % ont été transférés à un autre secteur, 17,7 % ont connu un échec thérapeutique et 7,1 % sont décédés. Au total, 63,2 % étaient des Iraniens, 36,1 % des réfugiés afghans. Malgré les efforts déployés pour la prévention, le diagnostic et le traitement des patients, la tuberculose demeure un problème important dans cette province. IntroductionTuberculosis (TB) remains a major global public health problem. The World Health Organization (WHO) estimated that in 1997 there were about 8 million new cases of TB and 2 million deaths worldwide; the great majority (95%) of these cases and deaths (98%) were in developing countries [1,2]. It was estimated that by 2000, the annual global number of new cases would have increased to over 10 million (163 per 100 000 population), and the annual expected number of deaths to 3.5 million per year (nearly 46 per 100 000 population) [3,4]. Today, TB remains common throughout most of the world with one-third of the world’s population estimated to be infected with Mycobacterium tuberculosis. The incidence of TB has recently started to rise again due to increased migration, a higher rate of direct transmission of M. tuberculosis and co-infection with HIV [5]. In 1999, the highest and lowest rates of TB in provinces of the Islamic Republic of Iran were reported to be 137 per 100 000 and 10 per 100 000 respectively [6]. The main goal of this study was to describe the incidence of TB and some demographic characteristics of TB patients over a 3-year period (1997–99) in Yazd province, in the central part of the Islamic Republic of Iran. MethodsYazd province covers an area of about 74 214 km2 and has an estimated population of 750 769 (385 936 males and 364 833 females). The study participants were patients with TB aged 8–65 years who were referred to the Yazd referral hospital during the study period (1997–99). Samples of sputum, tissue or body fluids were obtained and investigated by Ziehl–Neelsen staining and culture methods. Specimens were transported in broth media (Becton Dickinson, Maryland, USA) and processed on the same day if possible, or if delay was unavoidable, the specimens were stored at 4 °C for not more than 1 night before processing. On arrival at the laboratory, the presence of visible fibrinous clots was noted and Ziehl–Neelsen staining was applied. Cultures were obtained by inoculation into conventional solid Lowenstein–Jensen media (Difco). All inoculated cultures were incubated at 37 °C under 5% CO2. The culture media were investigated twice a week for the first 3 weeks and thereafter weekly for a total of 6 weeks incubation. All isolates were initially confirmed by Ziehl–Neelsen staining and subsequently identified by standard bio- chemical tests [7,8]. The collected data and results of laboratory tests were analysed by SPSS, version 6. ResultsA total of 604 cases of TB were identified during the study period. The overall mean annual rate of TB over the 3-year period was 26.8 per 100 000 population (Table 1).
There were 256 males and 339 females. There was no significant difference in the rate of TB between the sexes (P > 0.05); the mean annual rate was 22.9 per 100 000 for males and 31.0 per 100 000 for females. Breakdown of the data by age showed the lowest rate of TB was in the £ 10 years age group (7.0 per 100 000) and the highest rate among the > 50 years age group (111.1 per 100 000). Data analysis revealed that those aged > 50 years had a significantly higher rate than those in the younger age groups (P < 0.05).The nationality of the TB patients over the 3-year period showed a high proportion of the group were Afghan refugees (36.1%); 63.2% were Iranian and 0.7% other nationalities (Table 2). Of the 604 patients, 458 patients had pulmonary TB and 146 extra-pulmonary TB. The mean annual percentage of extra-pulmonary TB cases (24.2%) was much lower than for pulmonary TB cases (75.8%) (Table 2). The outcome of TB for this group of patients showed that on average 66.7% of patients were cured, 8.4% transferred to a different catchment area, 17.7% were treatment failures and 7.1% died (Table 2).
DiscussionThe technologically under-developed and developing countries carry an enormous share of the world’s TB burden. The disease is not uniformly distributed and some countries show a continuing increase in TB infection rates, whereas others show declining infection rates [9–11]. In industrialized centres, a rise of TB incidence has been observed, due to increased migration, a higher rate of direct M. tuberculosis transmission and the HIV epidemic. TB is a continuing threat to health in all parts the world [5]. The present study was carried out to monitor the incidence of TB and some demographic characteristics of TB patients in Yazd province in a 3-year period (1997–99). The average annual rate of TB during the study period was 26.8 per 100 000 population (23 per 100 000 among males and 31 per 100 000 among females). The rate of TB in our study is higher than the rate in some other areas in the world [6,12–15]. But, it is nearly equal to the lowest rate for developing countries (25 per 100 000), and one-ninth the highest rate for developing countries (240 per 100 000) [16]. Real increases in the numbers of TB patients cured will only occur when the Iranian Ministry of Health and Medical Education is able to either directly treat all cases of TB in Yazd province or at least influence the method of treatment applied in private practice and other health care services, such as university hospitals and military services. If the National TB Control Programme can achieve its target of DOTS [directly observed treatment, short-course] for all, it will have had a real impact on the problem of TB, not only immediately on incidence and mortality rates, but also in the longer term on TB prevalence. In addition, clinical mycobacteriology laboratories play an important role in the control of the spread of TB through the timely detection, isolation, identification and drug susceptibility testing of M. tuberculosis [17]. Today’s worldwide TB epidemic and the movement of a growing number of refugees have made TB control in refugee populations an issue of increasing importance. However, in developing countries TB control in refugee populations remains a largely unmet need. Experience shows that despite difficult field conditions, TB control programmes can be managed successfully in this setting [18]. It seems that despite the efforts which have been made in prevention, diagnosis and treatment of patients and refugees, TB is still a problem in this province. AcknowledgementsThe authors wish to thank Dr K. Ghazi-Saeedi, Dr M. Karimi, Dr M. Shayegh, A.A Sadrabadi, A.A. Hanafi-Bojd and F. Falah for their kind assistance in this study. References 1. Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden intervention and cost. Bulletin of the International Union against Tuberculosis and Lung Disease, 1990, 65:6–24. 2. Dye C et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. Journal of the American Medical Association, 1999, 282: 677–86. 3. Dolin PJ. Global tuberculosis incidence and mortality during 1990–2000. Bulletin of the World Health Organization, 1994, 72:213–20. 4. Dolin PJ, Raviglione MC, Kochi A. A review of the current epidemiological data and estimation of the future tuberculosis incidence and mortality. Geneva, World Health Organization, 1993. 5. Opravil M. Epidemiological and clinical aspects of mycobacterial infections. Infection, 1997, 25(1):56–9. 6. Setoudeh Maram E, Fararoei M. Incidence of tuberculosis in the cities of Fars. Journal of Qazvin University of Medical Sciences, 1999, 11:74. 7. Eisenstadt J et al. Mycobacterium tuberculosis and other nontuberculous Mycobacteria. In: Mahon CR, Manuselis G. Textbook of diagnostic microbiology, 2nd ed. Philadelphia, WB Saunders, 1995: 635–76. 8. Runyon EH. Mycobacterium. In: Lennette EH, Balows A, Housler WJ, eds. Manual of clinical microbiology. Washington DC, American Society of Microbiology, 1980: 150–79. 9. Hershfield ES. Tuberculosis in the world. Chest, 1979, 76:805–11. 10. Sutherland I et al. [Risques annuels d´infection tuberculeuse dans 14 pays d´après les résultats d´enquêtes tuber-culinques effectueés de 1948 à 1952. Annual risks of tuberculous infection in 14 countries derived from the results of tuberculin surveys in 1948–1952.] Bulletin of the International Union against Tuberculosis, 1971, 45:75–96. 11. Bleiker MA, Styblo K. The annual tuberculosis infection rate and its trend in developing countries. Bulletin of the Inter- national Union against Tuberculosis, 1978, 53:295–8. 12. Miller M, Leowski J. Epidemiology of tuberculosis in Poland and in the world. Przeglad epidemiologiczny, 1997, 51(4):389–404 [in Polish]. 13. Zuber P. Epidemiology of persistent tuberculosis in DeKalb county, Georgia, 1990–1996. Journal of the Medical Association of Georgia, 1999, 88(1):42–6. 14. Rivest P, Tannenbaum T, Bedard L. Epidemiology of tuberculosis in Montreal. Canadian Medical Association journal, 1998, 151(5):605–9. 15. Baldo V et al. Epidemiological aspects of tuberculosis in Padua Health District 1985–1996. European journal of epidemiology, 1998, 14(2):125–8. 16. Global tuberculosis control. WHO Report 2000. Geneva, World Health Organization, 2000. 17. Beverly G et al. Mycobacterium. In: Murray PR et al., eds. Manual of clinical microbiology, 7th ed. Washington DC, American Society for Microbiology, 1999.
|